# clm_2B9EF111FA51

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: research_and_development  
value: 2,888,000,000 United States dollar  
valid_from: 2022-12-31  
valid_to: 2023-12-31  
published: 2023-02-17  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_616A4BA20B30  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories research and development: 2,888,000,000 United States dollar", as of 2022-12-31 (until 2023-12-31). Claim clm_2B9EF111FA51, https://asof.is/claim/clm_2B9EF111FA51, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-17  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm (primary, SEC EDGAR 10-K FY2022, published 2023-02-17)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | research_and_development | 2,742,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_2B9EF111FA51](/claim/clm_2B9EF111FA51.md) | [clm_F186D437CBF8](/claim/clm_F186D437CBF8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.